Press Releases

Cookie Notification

We use cookies to collect information about how our website is used and to improve the visitor experience. You can change your browser's cookie settings at any time. Please review our privacy policy for more information. OK

As previously announced, seven posters relating to the physician sponsored Expanded Access Program for Epidiolex have been presented at the American Epilepsy Society Annual Meeting across Sunday, December 6 , and today Included within the information presented is new data issued in a poster

- Consistent with previously announced results from the initial Phase 3 trial, remaining trials fail to show superiority over placebo - - Pre-specified subgroup analyses of pooled U.S. patients demonstrated a statistically significant result for the primary endpoint and a number of secondary